US 5,028,452 – Process for abatement of industrial discharge of chlorofluorocarbon (FREON-like gases) pollutants, by conversion of such pollutants from a gas to a solid that could be safely disposed of. – This patented process covers the system adopted by semi-conductor manufacturers to abate the discharge of such FREON-like pollutants in their manufacture of semi-conductors; and, thereby enabled their compliance with EPA restrictions on such discharges.
US 4,517,159 – Method for the automated immunochemical analysis of biological fluid samples within a solid phase (filter paper) – This patented method covers the basic concept for “radial partition immunoassay“, the proprietary system embodied in the STATUS Immunochemistry Analyzer, marketed by Baxter Healthcare.
Nutramax Laboratories v. Inholtra Natural Ltd. & Inholtra, Inc. CIY-B-97-787 (Fed. DC Baltimore, MD) – Opinion as to non-infringement and invalidity of Nutramax patent rights. TASK – Infringement & Validity Opinion – Lead Counsel for Inholtra in the successfully defense of patent infringement claims against client, by successful re-examination of asserted patent in Patent Office proceeding, resulting in concession of invalidity by Nutramax Laboratories . Client, Inholtra Natural, subsequently sold its patented product to GNC for $13MM.
State Contracting & Engineering Corp. v. State of Florida Department of Transportation,97′ 7014-CIV-WPD (Fed DC SD Fla) TASK – Infringement & Validity Opinion – Analysis of Bone US Patents 5,234,288 & 5,429,455 – Method for construction of Sound Barrier Walls along interstate highways in Florida; review of contractual relationship between client & FDOT; and, the unavailability of equitable & legal defenses of Florida Department Of Transportation, to enforcement of Bone patent against Florida DOT, and its subcontractors . Litigation support (co-counsel) to trial counsel (6 years). Florida Department of Transportation settled with client on eve of trial second lawsuit-value of settlement to client (cash and non-cash consideration) estimated at between $20MM to $25MM;
Mr. Faro had responsibility for clearance of diagnostic test protocols for STRATUS Immunochemistry System – the first automated system for performance of immunoassays for drugs of abuse, pregnancy and wellness screens. Estimated annual revenues for product at time of the official product introduction >$50MM;
Mr. Faro had responsibility of clearance of INHOLTRA Natural Dietary Products for promotion of joint health. Opinion used and accepted by GNC (Pittsburgh, PA) in its decision to acquire product from my client for $13MM.
Mr. Faro, as Associate Licensing Counsel for BF Goodrich Company, had responsibility for support of senior management whose primary area of responsibility was the domestic and international licensing of “clean reactor” technology used in Vinyl Chloride monomer manufacture.
Due diligence review in support of SEC counsel preparation of private and public offerings of start-up companies: Holland & Knight; Akerman Senterfitt; Morgan Lewis & Bockius;